Kursprognose für Bicycle Therapeutics PLC (BCYC)BCYCBicycle Therapeutics PLC

Alphio's BCYC stock price prediction model matches the current Bicycle Therapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.75 (+0.94%). The 1-week path is $3.75 (+0.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Bicycle Therapeutics PLC (BCYC) is currently trading at $3.62, which is significantly below the Oppenheimer price target of $11, suggesting a potential upside of approximately 174%. However, the stock has shown a year-to-date decline of 45.81% and a 52-week range that indicates it is near its low of $3.33. While the gross margin remains strong at 96.8%, the company reported a substantial net loss of $10.48 million in Q3 2026, which is concerning. The RSI of 43.08 indicates the stock is nearing oversold territory, but the overall trend remains bearish. Given these factors, it may be prudent to hold rather than buy at this time, as the risks of further declines are present, especially with a recent earnings miss and declining revenues.

Bicycle Therapeutics PLC (BCYC) last closed at $3.72, gaining +1.36%. These facts feed the 1-day and 1-week BCYC price prediction above.